Can B Corp. (CANB)
OTCMKTS · Delayed Price · Currency is USD
0.0200
+0.0030 (17.65%)
Aug 26, 2025, 2:19 PM EDT
Can B Market Cap
Can B has a market cap or net worth of $1.80 million as of August 26, 2025. Its market cap has increased by 71.81% in one year.
Market Cap
1.80M
Enterprise Value
19.03M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since April 29, 2011, Can B's market cap has decreased from 25.26B to 1.80M, a decrease of -99.99%. That is a compound annual growth rate of -48.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 1.80M | -35.10% |
| Dec 31, 2024 | 2.78M | 234.74% |
| Dec 29, 2023 | 830.16K | -85.56% |
| Dec 30, 2022 | 5.75M | -72.61% |
| Dec 31, 2021 | 20.99M | 430.37% |
| Dec 31, 2020 | 3.96M | -57.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |